Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 278 active Bladder Cancer trials
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
Study Type: Interventional Phase 2
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
Study Type: Interventional Phase 2
Blue Light Cystoscopy With Cysview® Registry
Study Type: Observational
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
Study Type: Interventional Phase 2
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
Study Type: Interventional
Afatinib in Advanced Refractory Urothelial Cancer
Study Type: Interventional Phase 2
Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy
Study Type: Interventional Early Phase 1
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
Study Type: Interventional Phase 3
There are 278 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now